Mesenchymal stem cells (MSCs) are widely used in regenerative medicine. They can be isolated from different adult tissues. However, the regenerative potential of MSCs obtained from various sources and from different age donors may significantly differ.

Stem cell therapy for the treatment of cerebral palsy is a rapidly expanding area of research that has been identified as a high priority by consumers. There are several types and sources of stem cell therapies under investigation. Stem cell treatments proposed for cerebral palsy are believed to provide benefit via some or all of the following mechanisms including immunomodulation, paracrine signaling and supporting endogenous reparative processes.

The regenerative medicine landscape is undergoing its fastest change due to the breakthroughs in stem cell therapy. The versatility of stem cells places them at the frontline of medical research with a promise of the possibilities of treating numerous diseases, both degenerative and traumatic.